FDA Approves First Alzheimer’s Drug in Years | Philadelphia News

FDA approves Lecanemab, the first drug to target Alzheimer’s root cause by clearing amyloid plaques, offering a 27% slowdown in decline for early-stage patients—though costly and with risks, it’s a major leap forward in the fight against this devastating disease. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f84403b35bc7905d